
President Trump may be issuing an executive order to reschedule cannabis.

Our top cannabis news topics this week: NY OCM executive director resigns, biosolids for hemp fertilizer, Ohio SB 56 approved by Senate, enforcing new hemp legislation, and patterns of CBD use for dogs.

The Ohio Senate has approved Senate Bill 56 and has sent it to Governor Mike DeWine’s desk to become official legislation.

The report breaks down the structural challenges faced by the hemp markets in the region and highlights paths for growth.

The new CRS report outlines how enforcing the updated federal hemp definition and THC limits in products may be difficult for FDA and DEA.

New York OCM acting Executive Director, Felicia A.B. Reid, has been requested to resign from her position by Governor Kathy Hochul.

The cross-sectional analysis used hair follicle testing to determine THC use in individuals with schizophrenia, then compared MetS prevalence in cannabis consumers and non consumers.

High Tide announced that they are planning to open three new Canna Cabana locations in Calgary, London, and Brampton.

The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.

In a first-of-its-kind US field trial, The University of Illinois Urbana-Champaign, is exploring how hemp biosolids can be utilized as a sustainable fertilizer.

Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.

The research analyzed data from the Dog Aging Project, finding prevalence of use for certain conditions and behavior changes over time.

The Texas Department of Public Safety has announced a list of nine businesses that will move forward in Phase I of the Texas Compassionate Use Program.

Suncrafted and Tribal Fire have partnered together to launch the first licensed Native American cannabis product brand on the East Coast.

In a UK Biobank study on data from adults aged 60 and older, cannabis use was not found to cause widespread cognitive harm, though with mixed results on benefits and risks.

The retrospective observational study examined the effect of cannabis on the risk of alcohol-associated liver disease in patients with alcohol use disorder.

High Tide recently opened their first Canna Cabana location in Berlin, Germany.

The study compared the effects of a 30-day regimen of CBD oil or a placebo oil on stress in university students, compared to no treatment.

The hemp industry now faces significant changes with new federal regulations. Here's how operators must adapt, strengthen compliance, and pivot product lines to thrive.

Our top cannabis news topics this week: celebrating Green Wednesday, Ohio’s Senate Bill 56 updates, a message from the US Hemp Roundtable, Healer’s November webinar, and research on terpenes and the ECS.

In honor of Green Wednesday on November 26, 2025, we are excited to share with you our Green Wednesday-themed round up of medical cannabis research.

In this interview clip, Darwin Millard, Technical Director of CSQ, explains the importance behind the ASTM D37 Vape Device Safety & Testing Initiative.

In honor of Green Wednesday on November 26 2025, we are excited to share with you our green wednesday-themed round up of pre-roll manufacturing and processing.

As part of our Green Wednesday celebration, Cannabis Science and Technology is highlighting news and research for all things THC.

Check out our exciting 2025 Green Wednesday coverage!

With the new hemp provisions in the government reopening bill, the industry is working towards action to help address the effects of the hemp ban.

In this interview clip, Darwin Millard, Technical Director of CSQ, explains an example of "cannafraud" in the industry and how developing standards can combat these challenges.

Ohio’s Senate Bill 56 has been approved by members of the legislative conference committee, where the group has made revisions to the bill.

This month’s webinar explored recently published studies on cannabis for diabetic neuropathy, chronic low back pain, and opioid induced persistent apnea.

Study researchers from Israel recently discovered that cannabis terpenes can activate endocannabinoid receptors.